Safety of serial MRI in patients with implantable cardioverter defibrillators

Heart

Volumn 97, Issue 22, 2011, Pages 1852-1856

  Junttila, M Juhani ^a   Fishman, Joel E ^a   Lopera, Gustavo A ^a   Pattany, Pradip M ^a   Velazquez, Darcy L ^a   Williams, Adam R ^a   Trachtenberg, Barry H ^a   Sanina, Cristina ^a   Mather, Jacques ^a   Hare, Joshua M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTICAL PARAMETERS; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; ARTIFACT; BATTERY VOLTAGE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; DEFIBRILLATOR; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HIGH VOLTAGE LEAD IMPEDANCE; HUMAN; IMAGE QUALITY; INFERIOR MYOCARDIAL INFARCTION; ISCHEMIC CARDIOMYOPATHY; MALE; PACING CAPTURE THRESHOLD; PACING LEAD IMPEDANCE; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT SAFETY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 80055119442     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300153     Document Type: Article

References (13)

1. Faris OP, Shein M. Food and Drug Administration perspective: magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation 2006;114:1232-3. (Pubitemid 44402047)
2. Faris OP, Shein MJ. Government viewpoint: U.S. Food & Drug Administration: pacemakers, ICDs and MRI. Pacing Clin Electrophysiol 2005;28:268-9. (Pubitemid 40604037)
3. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005;28:326-8. (Pubitemid 40604048)
4. Stanton MS. Industry viewpoint: Medtronic: Pacemakers, ICDs, and MRI. Pacing Clin Electrophysiol 2005;28:265.
5. Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004;110:475-82. (Pubitemid 39031161)
6. Nazarian S, Roguin A, Zviman MM, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 2006;114:1277-84. (Pubitemid 44402053)
7. Naehle CP, Strach K, Thomas D, et al. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2009;54:549-55.
8. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-62.
9. Levine GN, Gomes AS, Arai AE, et al. American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, American Heart Association Council on Clinical Cardiology, American Heart Association Council on Cardiovascular Radiology and Intervention. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007;116:2878-91. (Pubitemid 350291228)
10. Roguin A, Schwitter J, Vahlhaus C, et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008;10:336-46. (Pubitemid 351773738)
11. Levine PA. Industry viewpoint: St. Jude Medical: Pacemakers, ICDs and MRI. Pacing Clin Electrophysiol 2005;28:266-7. (Pubitemid 40604036)
12. Anon. http://www.accessdata.fda.gov/cdrh-docs/pdf9/p090013a.pdf (accessed Jun 2011).
13. Wilkoff BL, Love CJ, Byrd CL, et al. Heart Rhythm Society, American Heart Association. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 2009;6:1085-104.